Sort
15,273 grants matching “antimicrobial resistance”
Centers for Research on Structural Biology of Infectious Diseases for Anti-Microbial Resistant Research
$1,656,388Peter Myler · Seattle Children'S Hospital · N01 · FY2024 · AI
Broad-Spectrum Antimicrobials Targeting the D-Alanine Pathway
$1,655,184Karen G. Anthony · L2 Diagnostics, Llc · U01 · FY2012 · AI
Funtion of Uncharacterized Genes of Acinetobacter baumanii
$1,653,016Samuel I. Miller · University Of Washington · U19 · FY2016 · AI
Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease
$1,650,504Steven J. Schiff · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · AI
**AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** ANTIMICROBIAL RESISTANCE (AMR) IS A SIGNIFICANT PROBLEM IN HEALTH CARE, ANIMAL HEALTH, AND FOOD SAFETY. TO LIMITAMR, THERE IS A NEED FOR ALTERNATIVES TO ANTIBIOTICS TO ENHANCE DISEASE RESISTANCE AND SUPPORT JUDICIOUSANTIBIOTIC USAGE IN ANIMALS AND HUMANS. MUCH LIKE HUMANS, NEONATAL AND JUVENILE FOOD ANIMALS ARE PARTICULARLYSUSCEPTIBLE TO DISEASE, AND METHODS TO ENHANCE DISEASE RESISTANCE IN FOOD ANIMALS WOULD BE DIRECTLYBENEFICIAL AND INFORMATIVE FOR ENHANCING HUMAN HEALTH. IMMUNOMODULATION IS A PROMISING METHOD TO ENHANCEDISEASE RESISTANCE AND PROMOTE ANTIBIOTIC STEWARDSHIP. ONE RAPIDLY EVOLVING FIELD OF IMMUNOMODULATION ISINNATE MEMORY (OR INNATE TRAINING), WHICH RELIES ON CELLULAR EPIGENETIC MODIFICATIONS THAT LEAD TO A HEIGHTENED(IE, TRAINED) RESPONSE FOLLOWING REPEATED MICROBIAL STIMULATION OF INNATE IMMUNE CELLS. OUR OVERALL GOAL IS TOUTILIZE INNATE TRAINING AS AN APPROACH TO ENHANCE DISEASE RESISTANCE IN A MANNER THAT IS HIGHLY RELEVANT TO BOTHAGRICULTURE AND BIOMEDICAL RESEARCH. WE WILL TEST A COMPOUND SHOWN TO BE SAFE IN ANIMALS AND HUMANS FOR IT'S ABILITY TO PROTECT PIGS AND CATTLE AGAINST DISEASES COMMON TO EACH INDUSTRY.
$1,650,000Agricultural Research Service · · FY2020 · National Institute of Food and Agriculture
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
$1,647,916Sarah M Fortune · Harvard Medical School · U19 · FY2023 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,639,038Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Immunobiology of Leprosy
$1,629,970Robert L Modlin · University Of California Los Angeles · P50 · FY2015 · AR
Immunobiology of Leprosy
$1,629,970Robert L Modlin · University Of California Los Angeles · P50 · FY2016 · AR
The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratios
$1,628,180Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2024 · AI
Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease
$1,627,982Steven J. Schiff · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · AI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network
$1,627,344Ebbing Lautenbach · University Of Pennsylvania · U54 · FY2023 · CK
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection
$1,626,624Herbert W Virgin · Washington University · U19 · FY2018 · AI
DEVELOPMENT OF DIAGNOSTICS FOR NEISSERIA GONORRHEAOE
$1,625,928Jeffrey Klausner · Social And Scientific Systems, Inc. · N01 · FY2016 · AI
Broad-Spectrum Antimicrobials Targeting the D-Alanine Pathway
$1,619,778Karen G. Anthony · L2 Diagnostics, Llc · U01 · FY2011 · AI
Funtion of Uncharacterized Genes of Acinetobacter baumanii
$1,615,295Samuel I. Miller · University Of Washington · U19 · FY2014 · AI
Infection Prevention and Antimicrobial Stewardship: Minding the Gaps: The Iowa Prevention Epicenter
$1,613,024Loreen A Herwaldt · University Of Iowa · U54 · FY2022 · CK
Excellence in Research for Emerging and Reemerging Diseases of Public Health Interest in Colombia at the National Institute of Health
$1,613,000Martha Ospina · Colombian National Institute Of Health · U01 · FY2021 · GH
Programmable benchtop bioreactors for scalable eco-evolutionary dynamics of the human microbiome
$1,607,516Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2025 · AI
University of Cape Town Clinical Trials Unit (UCTCTU)
$1,606,511Linda-Gail Bekker · University Of Cape Town · UM1 · FY2015 · AI
Biomolecular Structure and Mechanism, Structure-Based Drug Design
$1,606,306Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease
$1,606,082Steven J. Schiff · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · AI
Broad-Spectrum Antimicrobials Targeting the D-Alanine Pathway
$1,605,387Karen G. Anthony · L2 Diagnostics, Llc · U01 · FY2013 · AI
Epithelial Genes in Allergic Inflammation
$1,601,750Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2019 · AI
Genomic Sequencing Center for Infectious Diseases
$1,600,000Bruce Birren · Broad Institute, Inc. · N01 · FY2013 · AI